• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Atossa Therapeutics, Inc. - Common Stock (NQ:ATOS)

0.6306 +0.0406 (+6.88%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,547,295
Open 0.5926
Bid (Size) 0.6400 (1,200)
Ask (Size) 0.6500 (900)
Prev. Close 0.5900
Today's Range 0.5926 - 0.6340
52wk Range 0.5510 - 1.290
Shares Outstanding 125,785,200
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why Are Shares Of Atossa Therapeutics Up Today? ↗
December 11, 2025
Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock is trading higher on Thursday. Here's what investors need to know. 
Via Benzinga
Atossa Therapeutics Stock Jumps After FDA Grants Rare Pediatric Status To DMD Drug — Retail Bets On Phase 3 Fast-Track ↗
December 11, 2025
Via Stocktwits

Performance

YTD
N/A
N/A
1 Month
-17.0%
-17.0%
3 Month
-36.9%
-36.9%
6 Month
-25.4%
-25.4%
1 Year
-37.6%
-37.6%

More News

Read More
News headline image
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
December 11, 2025
Via Chartmill
News headline image
NioCorp and Atossa Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
August 29, 2025
Via ACCESS Newswire
News headline image
MicroMarvel - Atossa Therapeutics ↗
April 06, 2024
Via Talk Markets
News headline image
Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
August 01, 2025
Via ACCESS Newswire
News headline image
This Excelerate Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗
June 05, 2025
Via Benzinga
News headline image
Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22
May 20, 2025
Via ACCESS Newswire
News headline image
Atossa Therapeutics and Ainos Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
May 02, 2025
Via ACCESS Newswire
News headline image
Earnings Scheduled For March 25, 2025 ↗
March 25, 2025
Via Benzinga
News headline image
Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday ↗
September 11, 2024
Via Benzinga
News headline image
ATOS Stock Earnings: Atossa Therapeutics Beats EPS for Q2 2024 ↗
August 12, 2024
Via InvestorPlace
News headline image
3 Dirt-Cheap Drug Developers With Blockbuster Potential ↗
July 11, 2024
Via InvestorPlace
News headline image
3 Penny Stock Moonshots with 300%+ Upside Potential by 2025 ↗
July 03, 2024
Via InvestorPlace
News headline image
Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar ↗
June 07, 2024
Via InvestorPlace
News headline image
3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off ↗
May 20, 2024
Via InvestorPlace
News headline image
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 ↗
May 17, 2024
Via InvestorPlace
News headline image
ATOS Stock Earnings: Atossa Therapeutics Beats EPS for Q1 2024 ↗
May 13, 2024
Via InvestorPlace
News headline image
Shhh! 3 Secret Penny Stocks Flying Below Wall Street’s Radar ↗
May 09, 2024
Via InvestorPlace
News headline image
ATOS Stock Earnings: Atossa Therapeutics Misses EPS for Q4 2023 ↗
April 01, 2024
Via InvestorPlace
News headline image
Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market ↗
January 16, 2024
Via InvestorPlace
News headline image
This Drug Developer Is Dedicated To "Transforming The Breast Cancer Paradigm" ↗
October 24, 2023
Via Benzinga
News headline image
Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers - Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment
September 18, 2023
Via ACCESSWIRE
News headline image
Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers – Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment ↗
September 15, 2023
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
September 08, 2023
Via Benzinga

Frequently Asked Questions

Is Atossa Therapeutics, Inc. - Common Stock publicly traded?
Yes, Atossa Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Atossa Therapeutics, Inc. - Common Stock trade on?
Atossa Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Atossa Therapeutics, Inc. - Common Stock?
The ticker symbol for Atossa Therapeutics, Inc. - Common Stock is ATOS on the Nasdaq Stock Market
What is the current price of Atossa Therapeutics, Inc. - Common Stock?
The current price of Atossa Therapeutics, Inc. - Common Stock is 0.6306
When was Atossa Therapeutics, Inc. - Common Stock last traded?
The last trade of Atossa Therapeutics, Inc. - Common Stock was at 01/02/26 04:00 PM ET
What is the market capitalization of Atossa Therapeutics, Inc. - Common Stock?
The market capitalization of Atossa Therapeutics, Inc. - Common Stock is 79.32M
How many shares of Atossa Therapeutics, Inc. - Common Stock are outstanding?
Atossa Therapeutics, Inc. - Common Stock has 79M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap